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Abstract 
Calcium-phosphate materials have been increasingly 
employed in orthopedic and dental applications in recent 
years and are now being developed for use in nonin-
vasive surgery or as carriers for drug delivery systems. 
We developed an injectable bone substitute (IBS) for 
percutaneous orthopedic surgery which uses a biphasic 
calcium-phosphate (BCP) mixture composed of hydroxy-
apatite (60%) and /Hricalcium phosphate ( 40% ), togeth-
er with a polymer (hydroxy-propyl-methyl-cellulose, 
HPMC) as a carrier. The best BCP/polymer ratio was 
determined to achieve the highest mineral phase in the 
composite and provide the rheological properties 
required for injectable material. 
The in vivo biocompatibility and biofunctionality of 
ms were tested in rabbits using implants in subcutane-
ous, intramuscular and cartilage sites and defects created 
in trabecular bone of the femur epiphysis. The defects 
were filled with IBS, and histological studies were per-
formed after 1, 2, 4 and 12 weeks on decalcified and 
non-decalcified sections. Image analysis and backscat-
tered electron analyses were performed by scanning 
electron microscopy. 
This study demonstrated that HPMC is a non-toxic 
material which can be associated with calcium-phos-
phates to produce an IBS and create a matrix for deep 
cell colonization conducive to bone ingrowth. 
Key Words: Injectable bone substitute, biphasic cal-
cium phosphate, biomaterial. 
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Introduction 
In recent years, self-setting calcium-phosphate 
cements have proved of considerable interest in ortho-
pedic and dental applications [3 , 5, 13, 19, 20, 21, 22, 
23, 27, 29, 30]. Calcium-phosphate materials have also 
been used as components or fillers in polymeric compos-
ites [2, 14], in association with polymers such as 
polysaccharides [1] or elastin or collagen of animal 
origin [16] . However, these products have not proved 
efficient for bone osteoconduction and ingrowth [25]. 
Some ionic calcium-phosphate cements have been devel-
oped, including one used in clinical studies [5, 20]. Yet 
it has been clearly demonstrated that macropores are 
required for bone ingrowth [7, 12], and these materials 
are not macroporous [ 13, 25]. 
The aim of this study was to develop a ready-to-use 
injectable bone substitute (IBS) which could be effi-
ciently colonized by osteogenic cells. This material 
needed to be perfectly biocompatible and potentially 
resorbable (synthetic bone graft material) and needed to 
possess an initial plasticity suitable for the filling of bone 
defects. Good in situ cohesion is necessary until the 
implant is completely replaced by newly-formed bone. 
For this purpose, we developed a composite of cal-
cium-phosphate granules and a hydrosoluble polymer 
[32, 33]. Biphasic calcium phosphate (BCP) was chosen 
because of its efficiency as a bone substitute and in 
promoting bone ingrowth [6, 8, 9, 16]. Cellulosic 
ethers were selected on the basis of their applications in 
pharmaceutical systems and their biocompatibility in 
vitro [4, 17]. 
Materials and Methods 
Biomaterials 
Polymer solution (HPMC) Methylhydroxypropyl-
cellulose (HPMC-MP 824; Aqualon-Hercules, France), 
with an average molecular weight of 700,000, was pre-
pared in a 2% solution (w/w) by dissolving the powder 
in bidistilled water under stirring for 48 hours. Solution 
viscosity was adjusted to 14,000 mPa·s at 25°C by 
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Figure 1. Scanning electron micrographs ofBCP grains 
used for preparation of the composite, showing the wide 
range of particle size (a) and the aggregates of single 
crystals at a higher magnification (b). 
addition of water or polymer under the control of an 
LDVI + Brookfield viscometer (Brookfield, Stoughton, 
MA). 
Mineral Phase BCP granules [60% hydroxyapatite 
(HA), 40% fj-tricalcium phosphate (fj-TCP)] with a 
grain size of 80 to 200 p.m were obtained by crushing 
blocks of Triosite™ (Zimmer, Paris, France) and rid-
dling the powder (Analysette, Fritsch, Germany). 
Composite The IBS was prepared before implanta-
tion and injected similarly to conventional orthopedic 
cement {PMMA: poly(methylmethacrylate)}. The w/w 
ratio was 60% for the mineral phase and 40% for the 
polymer solution. 
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Figure 1. X-ray diffraction pattern (obtained at 40 kV 
and 30 rnA) of the mineral phase used for preparation of 
the composite. 
Sterilization The BCP powder was sterilized by 
steam at l20°C for 1 hour. The polymer solution was 
prepared in a clean room (class 100) in sterile condi-
tions. The composite was mixed just before implanta-
tion. 
Physie«H:hemical analysis X -ray diffraction (XRD) 
according to the AFNOR (Association Fran~se de Nor-
malisation) standard (S 94-066) for calcium phosphates 
was used to check the HA/t1-TCP ratio in BCP and in 
the IBS after air-drying. Powders were examined using 
a Siemens DSOOO Kristalloflex (Siemens, Iselin, NJ) in 
the range of 20° < 28 < 40°. 
Grain size Powder grain size was checked by 
scanning electron microscopy (SEM; JEOL 6300, 
Tokyo, Japan) and image analysis (Quantimet 500, 
Leica, Deerfield, IL). 
Animal experiment 
In vivo tests were performed according to AFNOR 
standard NF S90-703 (December, 1989) for surgical 
implants. The standard recommends the osseoua and 
non-osseouB implantation site. Eleven adult, female 
New Zealand white rabbits (controlled sanitary status), 
weighing between 2.5 and 3 kg, were selected. Two 
animals were sacrificed after 1 week, 3 after 2 weeks, 
3 after 4 weeks, and 3 after 12 weeks. 
Bone defects Bone defects were performed in a 
trabecular bone site of rabbit femoral and tibial epi-
physis. Under sterile conditions, an approach to the 
knee was made to reach the medial side of the tibia and 
femur. A bone defect with re&War borders (S mm in 
diameter and 12 mm in length) was produced by manual 
excavation parallel to the joint line without breaking the 
intramedullary canal in the joint space. Femoral bone 
defects were filled with o.s g of ms, whereas the right 
tibia defect was filled with BCP blocks, and the left one 
not filled (control). 
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In vi\10 studies of a new injectable bone substitute 
Figure 3. A homogeneous degradation front for BCP 
grains was observed after 1 week of subcutaneous 
implantation. 
Subcutaneous sites Two subcutaneous sites on 
each side of the ventral face were injected respectively 
with HPMC alone and ms. 
M uscle sites Four muscle sites in the paraspinal 
lumbar area were filled in a ,similar manner (2 with 
HPMC alone and 2 with ms). 
Cartilage site A new model of cartilage site was 
developed in the anterior border of rabbit ear. ms were 
implanted in the core of the cartilage. 
Histological and ultrastructural techniques 
Light microscopy Recovered samples were fixed 
with 10% neutral formaldehyde solution. Half of the 
samples were decalcified by a 5% HNO:J solution and 
embedded in paraffin for histological studies. Sections 
(7 ,.un) were stained using the Masson-Goldner tri-
chromic method [2.(1]. The other samples were embed-
ded in methylmethacrylate. All samples were sectioned 
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Figure 4. After 2 weeks of implantation, biomaterial 
appeared less dense from the surface to the core. 
with a LEITZ 1600 diamond saw (Leitz, Wetzlar, Gee-
many) into 50 to 100 I'm thi(fk slices. The slices were 
stained using Movat' s pentachrome and observed in nor-
mal and polarized light microscopy. X-ray microradio-
graphy was performed at 20 kV on these same sectiooa. 
Electron microscopic techniques After diamond 
saw sectioning, residual blocks were carbon-coated and 
examined by SEM (JEOL 6300) operating at 15 kV, and 
using backscattered electron imaging (BSE). 
Image analysis was performed on sections using a 
Quantimet 500 system (Leica). 
Results 
Before implantation 
Viscosimetry HPMC-MP 824 (2%) has a viscosity 
of between 15,000 and 20,000 mPa·s, without aggre-
gate formation. The non-ionic structure of HPMC was 
also taken into account in choosing a polymer in ordec 
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FigureS. Connective tissue was in direct contact with 
cartilage after 1 week of implantation in a cartilage site. 
to prevent strong interaction with ea2+. The optimal 
ratio for the BCP/polymer solution was 60/40 (w/w), as 
determined by the inflection of the viscosity curve. 
Grain size BCP granules observed in SEM showed 
a wide range of grain size (Fig. 1a). Measurements 
indicated that 46% of the volume was composed of par-
ticles 60-200 J.Lm, 21.5% was composed of 30-60 J.Lm 
particles, 26.1% was composed of 10-30 J.Lm particles, 
and 1.1% was made of less than 10 J.Lm sized particles. 
SEM revealed that the granules were composed of ag-
gregates of single crystals 1 to 5 J.Lm in diameter which 
were more or less associated by grain boundaries (Fig. 
1b). Microporosity, as determined by image analysis of 
SEM observations, represented 33% ± 0.5% of the 
grain surface area. 
Physico-chemical analysis XRD indicated the HA 
and t1-TCP content of the composite (Fig. 2). The 
HA!t1-TCP ratio was determined using the 28 peaks at 
31.81 o for HA and at 31.03° for t1-TCP, according to 
the method of LeGeros [24]. 
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Figure 6. Section of materials in a bone site studied in 
microradiography after 2 weeks of implantation. 
Histological results: I..ight microscopy 
(1) Subcutaneous and intramuscular sites: After 
1 week, no inflammatory reaction or fibrous encapsula-
tion was noted. A homogeneous degradation front was 
observed between the BCP grains (Fig. 3). After 2 and 
4 weeks, the resorption of microparticles was regular, 
and the biomaterial became less dense from the surface 
to the core (Fig. 4). No encapsulation membranes were 
observed with the decalcified technique, and there was 
an increase in the number of cells in the central zone of 
the implanted area. 
(2) Cartilage site: Connective tissue was in direct 
contact with cartilage after 1 week of implantation. The 
process appeared to be similar after 2 to 4 weeks of 
implantation (Fig. 5). 
(3) Bone site: After 1 and 2 weeks of implantation, 
a decrease in the density of the biomaterial surface was 
observed in conjunction with the organization of woven 
In vivo studies of a new injectable bone substitute 
Table 1. X-rays microanalysis of Ca and P content of the newly formed bone and the BCP grains remaining after 
implantation expressed in weight percentage (mean/standard error); n = 20; significant differences are < 5% . 
Weeks Ca 
Host bone (n = 60) 27.9/2.0 
2 Newly-fonned bone 25.7/4.8 
2 BCP 32.6/2.5 
4 Newly-fonned bone 23.3/4.0 
4 BCP 34.2/2.2 
12 Newly-fonned bone 28.8/1.4 
12 BCP 39.0/1.3 
Table 2. Image analysis performed on the surface area 
occupied by peripheral bone, newly-formed bone and 
residual BCP grains (mean/standard error); n = 10; 
significant differences are < 5% . Op. = operation. 
Post op. 
1 week 
12weeks 
Host 
bone 
48.9%/2.9 
49.3%/3.0 
Newly-fonned 
bone 
40.9%/2.3 
BCP 
grains 
56.3%/5.6 
46.3%/5.2 
38.1%/2.3 
bone matrix all around the larger particles. In micro-
radiography, BCP granules were linked to newly-formed 
bone (Fig. 6). 
After 4 weeks, bridges of woven bone appeared 
between the granules, but the biomaterial remained very 
dense in the central zone (Fig. 7). 
After 12 weeks, trabecular bone was observed all 
around and between the larger particles ( > 80 J.Lm) (Fig. 
8). These residual granules appeared to be completely 
covered with lamellar bone. Spaces previously occupied 
by the polymer were totally filled by newly formed 
bone, and smaller particles were no longer observed. 
Scanning electron microscopy SEM revealed bone 
ingrowth after only 2 weeks of implantation (Fi.J. 9). 
After a longer implantation time, lamellar bone was 
observed in direct contact with the larger BCP grains, 
without a fibroua interlace (Fig. 10). The spaces 
between the grains 8WTOWlded by newly-fOI'IIled booe 
were occupied by bone trabecules. Numerou8 osteocytes 
with a brOMd range of sizes were observed. 
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p Ca + P Ca/P 
13.0/0.8 40.9/2.6 2.2/0.1 
11.0/1.9 36.7/6.9 2.3/0.1 
15.8/1.9 48.3/4.6 2.110.1 
10.7/1.9 34.0/5.8 2.2/0.2 
16.6/1.8 50.8/2.1 2.110.2 
10.2/2.0 39.0/2.5 2.8/0.2 
19.0/2.0 58.0/3.2 2.110.2 
X-ray microanalysis Table 1 reports the calcium 
and phosphorus content of newly-formed bone in direct 
contact with BCP particles after 2, 4 and 12 weeks of 
implantation of host bone, as well as the number of BCP 
particles remaining after implantation. 
Image analysis Image analysis was performed 
before implantation and at 12 weeks after implantation. 
The surface occupied by host bone, newly-formed bone 
and BCP particles are reported in Table 2. 
After 12 weeks, the total surface area occupied by 
newly-formed bone and residual BCP grain was 79%. 
The size of these residual grains was 104 ± 32 J.Lm in 
diameter. 
Discussion 
Like Katthagen [19], we chose a model different 
from other cement-filling models. Defects have general-
ly been created in rabbit femoral epiphysis or in the 
intramedullary of canine femora [29]. Implantation in 
trabecular bone in our study was justified to test the 
efficiency of IBS in filling bone defects without large 
diffusion into trabecular bone and to determine the 
resorption and bone replacement which occur to the det-
riment of such material. To address certain questions 
raised by surgeons concerning the behavior' of BCP 
granules during injection in non-bone si&es, we al&O 
tested biocompatibility in subcutaneoua, intramuscular 
and cartilage implantation sites. 
Injectable bone subtititute cannot be compared to 
ionic bone cement which ia able to undergo a hardening 
process after JDixina of the components [5, 13, 16, 21, 
24, 25]. However, bone cella in IBS are able to invade 
the spacea created by the disappearance of the polymer, 
so that general bone ingrowth occunJ to the detriment of 
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Figure 7. After 4 weeks, bridges of woven bone appeared between the granules. 
Figure 8. After 12 weeks, trabecular bone was composed of a network of bone bridges between the larger particles. 
Figure 9. Scanning electron microscopy using backscattered electron imaging revealed bone ingrowth after only 2 
weeks of implantation in direct contact with BCP grains. 
Figure 10. After a longer implantation time (12 weeks), a greater amount of bone was observed in direct contact with 
the larger residual BCP grain, with no fibrous interface. 
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BCP grain resorption. The disappearance of the poly-
mer will be due to diffusion, and solubility in extracellu-
lar body fluid, or/and cellular activity. In time, a mech-
anical property can be observed due to the presence of 
bone [31]. Cellulose and its derivatives have long been 
used for medical purposes and can be selected to achieve 
this goal. 
The hydrosoluble polymer was mixed with calcium 
phosphate, a material well-known for its osteoconduction 
properties [9, 11] and ability to provide a scaffold for 
cell spreading. The efficiency of BCP is related to its 
capacity for partial dissolution, the long-term stability of 
HA, and the enhanced bioactivity of readily-soluble TCP 
[6, 8, 12]. Methylhydroxypropyl cellulose was chosen 
for its pseudoplastic properties, as well as its non-ionic 
structure which prevents strong interaction with ea2 + 
[17, 32]. The best ratio for the two components, in 
order to obtain an IBS with ,., high mineral content and 
a relatively low polymer conceatration, was 60% for the 
mineral phase and 40% for the polymer, as determined 
by the viscosity curve [31). 
Scanning electron microscopy investigations of 
reference BCP powder revealed that granules formed 
agglomerates 80-200 I'm in size, made up of 1 to 5 I'm 
individual micrograins. Due to the association with the 
polymer, a partial dissociation of these clusters released 
single crystals [15]. 
Some authors have demonstrated in viWJ that cellu-
losic derivative is biocompatible with bone [4, 18, 28]. 
In a previous study, Grimandi e1 al. [17] tested IBS in 
vitro and demonstrated its biocompatibility. With 
HPMC alone, no cytotoxicity was noted in short- and 
long-term assays. Until day 4, cell numbers increased 
in the same way for BCP, HPMC-MP 824 and compos-
ite. However, from day 4 to 21, the curves for BCP 
and composite showed a similar inhibition of cell prolif-
eration. Fibroblast culture, in the presence of HPMC-
MP 824, showed moderate inhibition of cellular growth 
after 10 days, probably as a result of changes in the 
ionic hotne08tasis of media. 
In our in viWJ studies, no extensive inflammatory 
reaction occurred at any implantation site, whether sub-
c~ or intramuscular. Direct contact between the 
biomaterial and soft tissues was achieved without encap-
sulation by the membrane. In cartilage site&, the compo-
site wu embedded into a well~rganized tiuue as 
fibrous cartilage. 
The biofunctionality of IBS relates to ita two levels 
of porosity. The microporosity of BCP grains is neces-
sary for fluid circulation and to induce the dissolu-
tion/precipitation process for calcium-phosphate crystals 
[10]. Cellulosic polymer creates space6 between BCP 
graina which are conducive to angiogenesis and cell 
colonization (osteogenic and &tromal cells). These 
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spaces act like macropores in calcium-phosphate im-
plants. The mechanism of resorption of such biomater-
ial is centripetal, with a homogenous di880lution front 
relative to macrophage and/or osteoclast-like cell activ-
ities. Macrophages invade the composite from the sur-
face to the core, resorbing smaller BCP particles (less 
than 20 I'm), and releasing the cellulosic carrier. In our 
study, residual particles were about 100 I'm in diameter 
three months later, which would appear to be a minimal 
or critical size to be a scaffold for cell adhesion. The 
mechanism of HPMC disappearance is still unknown. 
It has never been demonstrated that animal cells can 
synthesize cellulase. However, phagocytosis, washing 
out, or oxidative hydrolysis of HPMC may occur. 
The calcium/phosphorus ratio of newly-formed bone 
appeared to be quite constant (around 2.2), similar to 
that of host bone. The mineral (calcium +phosphorus) 
content (weight%) of newly-formed bone increased sig-
nificantly ( < 5%) with aging (from 36.7% to 39.0%), 
while the mineral content of BCP grains increased at the 
same time (from 48.3 at 2 weeks to 58.0 after 12 weeks, 
significant difference < 5%). The changes in the min-
eral content of the implanted area can be accounted for 
by two processes. First, at the BCP grain level, carbon-
ated apatite (CHA) is precipitated into the micropores. 
This phenomenon was first described by Daculsi e1 al. 
[8, 10] and confirmed by clinical studies [6, 11]. These 
physico-chemical changes in BCP and mineral content 
increase the mechanical properties ofBCP material [31]. 
Secondly, bone ingrowth completely fills the spaces p~ 
viously occupied by the polymer. Osteoblasta synthesize 
an osteoid matrix, forming bone trabeculae between 
particles. The three-dimensional network of collagen 
fibers of the extracellular matrix appeared to be well-
orientated after the first month, and mineralization 
progressed regularly. After 4 and essentially 12 weeks, 
bone remodelling was observed. The physico-cllemical 
process and the cellular events involved bone ingrowth 
to the detriment of the composite. The mean surface 
area occupied by BCP grains and newly-formed bone 
reached 80% of the total area after 12 weeks. 
It may be coo.cluded that injectable HPMC-BCP cer-
amic coostitutes a truly new type of bone filler which 
could provide an alternative to ionic cement for obtain-
ina boo.e ingrowth within the core of the material. 
Moreover, this ready-to-use IBS, like macroporous 
ceramic, can be colonized by osteogenic cells. 
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Discussion with Reviewers 
A.A. Campbell: The authors talk of the micro- and 
macro-porosity having an effect on bone formation. 
Howevec, they do not mention the porosity of the BCP 
particles. 
Authors: The microporosity of the BCP grains was 
33 % according the ~ification of the initial raw 
material (TRIOSITE Zimmer). About the "macro-
pores• of ms, we can only make speculation because 
macropore are defined for bulk materials. For example, 
the macropore into TRIOSITETM Zimmer ware in the 
range of 400 to 600 I'M· The spaces in mS are filled 
by the polymer and water, the spaces are equivalent or 
larger to the size of the lf&ina, in our composition, 
about 100 to 250 I'M> and can represent 40% of the total 
volume. 
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A.A. Campbell: It is not clear whe&bea- the autbora are 
statiQa that the BCP is undergoing diuolutioa/reprecipi-
tation, or if the cells are involved in the remodelina of 
this material. 
Authon: Initial studies on BCP have demonstrated that 
biological fluid involves a dissolution and precipitation 
process [8, 10, 34, 35, 36]. In addition, cell activity in-
creases the process. These events are largely described 
in the literature, obtained from both in vitro and ill vivo 
studies. 
R. Todescan: Could the authors provide ratiooale for 
using subcutaneous, muacu1ar and cartil.aae site& for 
testing this bone su¥itute material? Would it not be 
sufficient to use one non-bony site? 
Authors: Tbe AFNOR standard recollllllelld oueous 
and non-oueous implantation site. It is considered that 
during implantation, particularly for injectable material 
the material implanted will be in contact with soft tissue. 
R. Todescan: Before preparing the ms, the if&Dulo-
metry of the mineral phase was between 80 and 200 I'm, 
however, granulometry (SEM) before the implantation 
revealed that 46 % of the granules on the IBS wece 6()... 
200 I'm, and the rest were of smaller size. Is thia the 
result of the composite preparation? 
Authon: I agree with your comment the initial if&Dul-
ometry was modified during the incubation of the poly-
mer and the mineral phase. The process will be due to 
partial dissolution of grain boundary releasing lingle 
crystals or smaller grains. 
R. Todescan: Information on the polymer degradatioo 
(in Discussion, referred to as "disappearance•) is 
needed, for example, tensile properties, degradation 
rates and mechanisms. 
Authon: The determination of the process of the 
disappearance of the polymer still unknown and wu dif-
ficult to characterize. We can only speculate. It could 
be due to dissolution in biological fluid, cell activity and 
others. We are actually trying to determinate the 
process of di880lution. 
R. Todescan: Evidence for the cellular activities 
(macrophages/osteoclasts): as the authors indicated, oeUs 
should "potentially reabsorb" this material. However, 
there is no evidence showing thia phenomena u judged 
by the micrographs. 
Authon: The undecalcified sectiODB used in this study 
favored data on the mineral phase and mineralized tissue 
ingrowth. Tbe different cell lines remaina difficult to 
differentiate. We present, howevec, evidence of multi-
nucleated oells. 
\ 
F. Millot et al. 
K. King: Given that HPMC is water soluble, how do 
the authors think that the sterilization process affected 
the stability of the polymer? 
Authors: We have tested in previous studies different 
ways for sterilization. Only steam sterilization does not 
cbanae the vi&C08i.ty of the polymer after solubilization. 
Moreover' using FTIR, no change on the structure of the 
polymer was detected. 
K. King: The results of the X-ray microanalysis dem-
onstrated that the CafP ratio of the BCP did not vary 
with time, however, it is &88U.IIled that the TCP phase 
within the cement was being resorbed and that carbon-
ated apatite was being deposited. Would the authors like 
to comment? 
Authors: We said that no significant differences will be 
detected. The standard error is higher than the differ-
ence that we can observed by the disappearance of the 
TCP content. Moreover, the biological apatite precipita-
tion is constituted of Ca deficient carbonated apatite and 
not stoichiometric. 
K. King: What evidence has lead to the conclusion that 
100 I'm is a minimum or critical size for cell adhesion? 
Authors: This comment is based on the observation. 
All the osteoconduction process and bone formation ob-
served at the expense of the grains are observed on the 
larger size particles. We have realized a recent study to 
demooBtrate the critical size of the particle for cell 
adheaion and/or cell resorption activity, in rata, and we 
can confirm this observation [37]. 
Reviewer V: HPMC is not shown in the study to be 
"non-toxic. • Nor is HPMC shown to create a matrix 
for deep cell coloni.ution leading to osteogenesis. 
Rather, it shows inhibitory phenomena compared to the 
undefined control. 
Authors: HPMC was demonstrated in the literature to 
be non-toxic. In the text, we did not indicate that 
HPMC is a matrix for cell colonization. We said that 
HPMC involved spaces between the BCP &rains in IBS, 
and the release of the polymer after implantation &ive 
spaces for bone in&rowth. However, it is well known 
by cell biologiata that HPMC ill a suitable matrix for 
three-dimensional cell culture, as well as collagen 
spon&e. 
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